Atlas Trials

Stannsoporfin With Light Therapy for Newborn Babies With Jaundice

Clinical trial NCT01887327 · COMPLETED

Trial details

NCT number
NCT01887327
Sponsor
InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Jaundice, NeonatalHyperbilirubinemia, Neonatal
Start date
2013-10-16
Primary completion
2016-03-22
Enrollment
91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.